Robert S. Sloviter

Affiliations: 
University of Arizona, Tucson, AZ 
Area:
Epilepsy
Google:
"Robert Sloviter"
Mean distance: 13358.2
 
Cross-listing: Neuropathology Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chun E, Bumanglag AV, Burke SN, et al. (2019) Targeted hippocampal GABA neuron ablation by Stable Substance P-saporin causes hippocampal sclerosis and chronic epilepsy in rats. Epilepsia
Bumanglag AV, Sloviter RS. (2018) No latency to dentate granule cell epileptogenesis in experimental temporal lobe epilepsy with hippocampal sclerosis. Epilepsia
Klein P, Dingledine R, Aronica E, et al. (2017) Commonalities in epileptogenic processes from different acute brain insults: Do they translate? Epilepsia
Carpenter-Hyland E, Bichler EK, Smith M, et al. (2017) Epileptic pilocarpine-treated rats exhibit aberrant hippocampal EPSP-spike potentiation but retain long-term potentiation. Physiological Reports. 5
Sloviter RS. (2017) Epileptogenesis meets Occam's Razor. Current Opinion in Pharmacology
Dingledine R, Coulter DA, Fritsch B, et al. (2017) Transcriptional profile of hippocampal dentate granule cells in four rat epilepsy models. Scientific Data. 4: 170061
Fares RP, Belmeguenai A, Sanchez PE, et al. (2013) Standardized environmental enrichment supports enhanced brain plasticity in healthy rats and prevents cognitive impairment in epileptic rats. Plos One. 8: e53888
Sloviter RS, Bumanglag AV. (2013) Defining "epileptogenesis" and identifying "antiepileptogenic targets" in animal models of acquired temporal lobe epilepsy is not as simple as it might seem. Neuropharmacology. 69: 3-15
Sloviter RS, Lømo T. (2012) Updating the lamellar hypothesis of hippocampal organization. Frontiers in Neural Circuits. 6: 102
Sloviter RS. (2011) Progress on the issue of excitotoxic injury modification vs. real neuroprotection; implications for post-traumatic epilepsy. Neuropharmacology. 61: 1048-50
See more...